[PANAMY] QoQ Annualized Quarter Result on 31-Mar-2019 [#4]

Stock
[PANAMY] PANASONIC MANUFACTURING MSIA
Announcement Date
28-May-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Mar-2019
Quarter
31-Mar-2019 [#4]
Profit Trend
QoQ- -4.78%
YoY- -19.28%
Quarter Report
Latest QR
Upcoming QR
PANAMY's Result
PANAMY's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 1,129,773 1,159,974 1,165,600 1,127,886 1,202,998 1,228,750 1,222,272 -5.09%
PBT 143,089 150,346 140,352 131,310 142,161 152,818 131,836 5.59%
Tax -27,502 -34,590 -31,992 -25,558 -31,100 -34,286 -31,280 -8.20%
NP 115,586 115,756 108,360 105,752 111,061 118,532 100,556 9.70%
-
NP to SH 115,586 115,756 108,360 105,752 111,061 118,532 100,556 9.70%
-
Tax Rate 19.22% 23.01% 22.79% 19.46% 21.88% 22.44% 23.73% -
Total Cost 1,014,186 1,044,218 1,057,240 1,022,134 1,091,937 1,110,218 1,121,716 -6.48%
-
Net Worth 795,165 766,614 863,808 837,079 823,715 799,417 906,937 -8.37%
Dividend
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Div 12,149 18,223 - 137,285 12,149 18,223 - -
Div Payout % 10.51% 15.74% - 129.82% 10.94% 15.37% - -
Equity
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Net Worth 795,165 766,614 863,808 837,079 823,715 799,417 906,937 -8.37%
NOSH 60,746 60,746 60,746 60,746 60,746 60,746 60,746 0.00%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin 10.23% 9.98% 9.30% 9.38% 9.23% 9.65% 8.23% -
ROE 14.54% 15.10% 12.54% 12.63% 13.48% 14.83% 11.09% -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
RPS 1,859.83 1,909.55 1,918.81 1,856.72 1,980.38 2,022.77 2,012.10 -5.09%
EPS 190.67 190.00 180.00 174.00 182.67 196.00 164.00 10.53%
DPS 20.00 30.00 0.00 226.00 20.00 30.00 0.00 -
NAPS 13.09 12.62 14.22 13.78 13.56 13.16 14.93 -8.37%
Adjusted Per Share Value based on latest NOSH - 60,746
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
RPS 1,831.82 1,880.78 1,889.91 1,828.76 1,950.55 1,992.30 1,981.79 -5.09%
EPS 187.41 187.69 175.70 171.47 180.08 192.19 163.04 9.70%
DPS 19.70 29.55 0.00 222.60 19.70 29.55 0.00 -
NAPS 12.8928 12.4299 14.0058 13.5724 13.3557 12.9618 14.7051 -8.37%
Price Multiplier on Financial Quarter End Date
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Date 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 -
Price 37.00 37.80 39.40 37.70 37.68 38.56 37.34 -
P/RPS 1.99 1.98 2.05 2.03 1.90 1.91 1.86 4.59%
P/EPS 19.45 19.84 22.09 21.66 20.61 19.76 22.56 -9.39%
EY 5.14 5.04 4.53 4.62 4.85 5.06 4.43 10.38%
DY 0.54 0.79 0.00 5.99 0.53 0.78 0.00 -
P/NAPS 2.83 3.00 2.77 2.74 2.78 2.93 2.50 8.59%
Price Multiplier on Announcement Date
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Date 26/02/20 25/11/19 27/08/19 28/05/19 27/02/19 26/11/18 29/08/18 -
Price 33.90 37.14 40.90 37.90 38.12 38.20 40.16 -
P/RPS 1.82 1.94 2.13 2.04 1.92 1.89 2.00 -6.07%
P/EPS 17.82 19.49 22.93 21.77 20.85 19.58 24.26 -18.54%
EY 5.61 5.13 4.36 4.59 4.80 5.11 4.12 22.78%
DY 0.59 0.81 0.00 5.96 0.52 0.79 0.00 -
P/NAPS 2.59 2.94 2.88 2.75 2.81 2.90 2.69 -2.48%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment